FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Amoxicillin and clavulanate potassium submitted by Hikma Pharmaceuticals USA Inc., updating the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Sinusitis
• Community-acquired Pneumonia
• Intra-abdominal Infection
• Otitis Media
• Skin and Skin Structure Infections
• Urinary Tract Infection

Drugs mentioned

• AMOXICILLIN AND CLAVULANATE POTASSIUM (amoxicillin and clavulanate potassium)

Snippet

SUPPL AP for AMOXICILLIN AND CLAVULANATE POTASSIUM (AMOXICILLIN AND CLAVULANATE POTASSIUM)